Freshpet Inc
Q3 2025 Earnings
Market Reaction
S&P 500 over the same 30 days: +0.15%.
Did FRPT Beat Earnings? Q3 2025 Results
Freshpet delivered a headline-grabbing Q3 2025 beat, with GAAP earnings per share of $1.86 eclipsing the $0.40 consensus estimate by 359.83%, though the result was heavily shaped by a one-time $77.90 million deferred tax asset valuation allowance release that drove net income to $101.66 million. Strip away that discrete tax benefit and the underlying story remains constructive: net sales grew 14.0% year-over-year to $288.85 million, edging past the $283.73 million consensus by 1.80%, propelled by volume gains of 12.9% and favorable price/mix of 1.1%. Adjusted EBITDA climbed to $54.61 million, with margin expanding 170 basis points to 18.9%. Looking ahead, management trimmed full-year 2025 guidance to reflect a more cautious consumer backdrop, narrowing net sales growth to approximately 13% and Adjusted EBITDA to $190 to $195 million, while reducing capital expenditures to roughly $140 million; the company now expects to be free cash flow positive for the full year, a milestone reached one year ahead of its original target.
- Volume gains of 12.9% drove majority of 14.0% net sales growth
- Favorable price/mix of 1.1%
- Household penetration growth of 10% YoY to approximately 14.8 million households
- MVP household penetration growth of 15% YoY
- Input costs as a percentage of net sales decreased 50 basis points YoY
- SG&A as percentage of net sales decreased 480 basis points due to lower share-based compensation and variable compensation accruals
- Discrete $77.9 million deferred tax benefit from release of valuation allowance due to sustained profitability
“We are quickly adjusting to the new economic reality and remain one of the best performing pet food businesses—with strong financial and operational results and category-leading growth.”
Freshpet CEO, on the earnings call
Forward Guidance & Outlook
Freshpet updated its full-year 2025 guidance: net sales growth of approximately 13% (narrowed from 13-16%); Adjusted EBITDA of $190-$195 million (narrowed from $190-$210 million); capital expenditures of approximately $140 million (reduced from ~$175 million). The company expects Adjusted Gross Margin to be flat for the year, media spending as a percentage of sales to exceed 2024 levels, and to end the year with approximately $265 million in cash. Freshpet now expects to be free cash flow positive for full-year 2025, a year earlier than originally anticipated. Capital spending in 2026 is estimated to be in line with 2025 unless the company decides to accelerate new technology or has a sizable retail expansion. Longer-term 2027 targets include 22% Adjusted EBITDA margin and 48% Adjusted Gross Margin.
FRPT YoY Financials
Figures from SEC filings and company reports. Not investment advice.